chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Passed out and fell off exam table hitting head on floor; contusion noted on right parietal area of skull. Vitals taken, neuro exam all normal following incident. Mother picked him up and drove him home.
Bad flu after receiving the vaccine; Mild soreness in the arm at the injection site; chills; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Bad flu after receiving the vaccine), VACCINATION SITE PAIN (Mild soreness in the arm at the injection site), CHILLS (chills) and FATIGUE (fatigue) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 021C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced VACCINATION SITE PAIN (Mild soreness in the arm at the injection site), CHILLS (chills) and FATIGUE (fatigue). On an unknown date, the patient experienced INFLUENZA (Bad flu after receiving the vaccine). In May 2021, CHILLS (chills) and FATIGUE (fatigue) had resolved. At the time of the report, INFLUENZA (Bad flu after receiving the vaccine) and VACCINATION SITE PAIN (Mild soreness in the arm at the injection site) outcome was unknown.            No concomitants were reported. No treatment was reported.   This case was linked to MOD21-089318, MOD21-073020, MOD21-073037, MOD21-073047 (E2B Linked Report). This case was linked to MOD-2021-073552 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: AE updated.; Sender's Comments:  MOD21-089318: MOD21-073020: MOD21-073037: MOD21-073047:
At approximately 1350, patient reported feeling anxious. Upon assessment, pt was pale, diaphoretic and shaky. At approximately 1340, he c/o chest pain and SOA. RRT called. Pt reports that he took 0.5 mg Ativan right after he received the injection (1340). 1359 - Pt no longer pale, diaphoretic. 1351 - 160/100 HR 103 (R) 1352 -163/90 HR 96 (L) 1356 - 145/93 HR 96 (L) 1359 - 140/88 HR 90 (L) 1400 - Pt denies chest pain, SOA, palpitations. Reports that he does not need to be seen in ED for further treatment.
This spontaneous report as received from a registered nurse refers to a 14 year old male patient. On an unspecified date in August 2012 (a year ago), the patient was vaccinated with his first dose of GARDASIL (dose, route and lot # not reported). The patient was then administered the second dose of GARDASIL in June 2013 on an unspecified day. The third dose of GARDASIL was administered on 07-aug-2013. Nurse stated that the second and third doses of GARDASIL were only separated by two months. No adverse effects reported. Additional information has been requested.
By midnight after my vaccine: Shortness of breath.  Three days later around 6:25 am on April 15, 2020: I got out of bed, next moment I recall is of me on the floor. No memory of falling. I was shaking uncontrollably as if my body was getting many commands at the same time but I had no control over it. I could not call out for help. At one point I was biting my right  hand but could not make myself stop until my shaking stopped. Bite did not penetrate skin but I had visible bite mark on my hand.  I regained control suddenly and just got up slowly and shaken by the experience. Wife then drove me to the ER.  Been feeling pressure on my head.
Patient was 17 at time of administration- parents reported incorrect date of birth to sign up for vaccination- unaware of error until post vaccination when talking personally with patient and asked literal age number.
Swelling in left arm Thursday evening following fluzone vaccination. Area was not red or warm.  Fluid filled area that had mild discomfort and resolved Sunday evening.
Started having joint pains that have steady and progressively gotten worse. She is now currently being seen by a Rheumatologist at Hospital and being treated for Rheumatoid arthritis symptoms, although she is not actually diagnosed with the disease as yet.
Pt was given PENTACEL and PEDVAX at the same visit. No adverse reactions.
Ten to fifteen seconds after receiving the hepatitis vaccine, the patient's eye rolled backwards and he lost his balance, falling off the chair in which he was sitting. After resting on the examination table for a while, patient recovered without any treatment.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On 22-AUG-2017 the patient was vaccinated with an expired dose of VARIVAX (lot # L021215, expiration date 10-JUN-2017) that was mixed with STERILE DILUENT (Lot number and expiration date unspecified) for prophylaxis. Verified diluent was not expired. No adverse effects were reported.
administered 10 doses of Moderna as a booster and later realized the vial was expired; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered 10 doses of Moderna as a booster and later realized the vial was expired) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered 10 doses of Moderna as a booster and later realized the vial was expired). On 03-Jan-2022, EXPIRED PRODUCT ADMINISTERED (administered 10 doses of Moderna as a booster and later realized the vial was expired) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2022-438657, MOD-2022-438669, MOD-2022-438670, MOD-2022-438671, MOD-2022-438673, MOD-2022-438674, MOD-2022-438675, MOD-2022-438676, MOD-2022-438677 (Patient Link).
Information was received from a physician concerning 5-10 immunocompromised patients over the age of 65 years. This report refers to the patients with chronic obstructive pulmonary disease (COPD). The physician revaccinated the patients with PNEUMOVAX 23 every 10 years. No adverse effects reported. This is one of the two cases received from the same reporter. Additional information is not expected as we can not contact the physician.
Redness/swelling (approx. 2 inches in diameter) at injection site 8 days after first shot. No treatment/has not resolved at this time.
This case was reported in a literature article and described the occurrence of pertussis in a 2-year-old subject of unspecified gender who was vaccinated with DTaP (manufacturer unspecified). Concurrent medical conditions included rhabdomyosarcoma for which chemotherapy had been started after he had completed the course of vaccinations. The authors report that no coughing contact was identified for the subject. No further information regarding the subject's medical, family history or concurrent medication has been provided. On unspecified dates, the subject received 4 doses of DTaP vaccine (unknown route, injection site and batch number). In 2012, at an unspecified time after vaccination with DTaP vaccine, the subject experienced pertussis. No information has been provided regarding any symptoms displayed by the subject or any clinical examinations performed on him; but the authors report that the pertussis cases described in the article had to have at least one of the following symptoms along with a nasopharyngeal polymerase chain reaction positive test for Bordetella pertussis to be considered as confirmed pertussis cases: paroxysmal cough, whoop or post-tussive emesis. Therefore, this was considered as a vaccination failure. In 2012, the subject also experienced RSV infection (rhinitis). His level of white blood cells at presentation was 200/ mm3 (83% lymphocytes) and it rose to a maximum of 31000/mm3 (3% lymphocytes) during the course of the illness. The subject was treated with a prolonged extracorporeal membrane oxygenation course including necrotizing pneumonia and tumour progression. Neither leukophoresis nor exchange transfusion was performed. The subject died from death unspecified 78 days after the onset of pertussis. An autopsy was performed and showed evidence of pulmonary fibrosis and pulmonary hypertension. Lung metastasis and metastases to pericardium were noted. There was no evidence of ongoing infection.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (COMIRNATY), on 31Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 39 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "ulcerative colitis" (unspecified if ongoing); "Seasonal allergies" (unspecified if ongoing), notes: Seasonal allergies. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (10Jun2022) negative, notes: day 8; (11Jun2022) negative, notes: day 9; (12Jun2022) negative, notes: day 10; (Jun2022) positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment. The patient previously receive a COVID-19 Vaccine.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Pt stated numbness and tingly left arm x 7 days on 7-16-07 that radiates to palm (left).
patient experienced elevated blood pressure, fever, weakness, leg pain, elevated heart rate, and dizziness
Left arm pain immediately with injection. After 30 minutes c/o pain down arm to the fingers with numbness. C/o injection too high.
Sick, in bed/ in the bed for 5 or 6 days, kind of nasty; After all the vaccines she was in pain; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (Sick, in bed/ in the bed for 5 or 6 days, kind of nasty) and PAIN (After all the vaccines she was in pain) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012220A) for COVID-19 prophylaxis.     Concurrent medical conditions included Thyroid disorder NOS (Thyroid thing for 25 years), Night terrors, Dry eyes, Anxiety, Pollen allergy (Outdoor allergies pollen) and Allergy to plants (Pine trees). Concomitant products included SERTRALINE HYDROCHLORIDE (ZOLOFT) for Anxiety, CICLOSPORIN (RESTASIS) for Dry eyes, CLONAZEPAM for Night terrors, CETIRIZINE HYDROCHLORIDE (ALLERGY RELIEF [CETIRIZINE HYDROCHLORIDE]) for Pollen allergy and Allergy to plants, LEVOTHYROXINE for Thyroid disorder NOS, ALIROCUMAB (PRALUENT), EZETIMIBE, METOPROLOL SUCCINATE and VITAMINS NOS for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Sick, in bed/ in the bed for 5 or 6 days, kind of nasty) and PAIN (After all the vaccines she was in pain). At the time of the report, ILLNESS (Sick, in bed/ in the bed for 5 or 6 days, kind of nasty) and PAIN (After all the vaccines she was in pain) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Concomitant medication include Fish gel pills and centrum vitamins everyday.  It was reported that the patient was sick, in bed, complaining. No treatment information was reported.   This case was linked to MOD-2022-629219, MOD-2022-629221 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Aug-2022: Live follow up received contains non-significant information.
patients received a dose of Prevnar 13 and then 2 doses of pneumovax23; one dose of prevnar and 2 doses of pneumovax 23; patients received a dose of Prevnar 13 and then 2 doses of pneumovax23; This spontaneous report was received from a consumer via other company Pfizer (# 2019225777) refers to unspecified number of patients older than 65 years of age with unknown gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients received a dose of pneumococcal 13v conj vaccine (crm197)(PREVNAR 13) (dosing details unspecified) followed by 2 doses of pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) (dose, strength, vaccination site, route, # lot, expiry date unspecified) for prophylaxis.
10/25/18 at 8:28pm daughter reported to pharmacy that pt experienced fever 99.2 degree F, arm pain and swelling, headache, neck pain, bump on head beginning 10/24/18 but symptoms worsened 10/25/18. Pt refused to seek medical help but symptoms subsided since we followed up with patient's daughter on 10/30/18 at 12:41pm bump on head still there but no pain.
Fever of 100.1; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100.1) and HEADACHE (Headache) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 065F21A, 002B21A and 002M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever of 100.1) and HEADACHE (Headache). At the time of the report, PYREXIA (Fever of 100.1) and HEADACHE (Headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.1 (High) 100.1.         No pre existing condition and allergy was reported. No concomitant drug details were reported. No treatment details were reported.
A 33 Female patient present with itchy in the right arm after the administration of there first dose of Pfizer  Lote#FF2588. Patient was in the observation area Paramedic noted that the patient have itchy in the administration site. Patient said to the paramedic that she take a Zyrtec 10mg before the administration. Vitals sing was HR:76, O2 96%, RR 19, BP 130/70, Glucose 101 and Temp: 97.7. We consult with Dr. and she give the order to administrated 6:45pm 4mg/ml dexthametasone on the left arm.  At 7:15pm Paramedic do reevaluation BP; 130/70, HR; 71, O2 98% RR 19 and patient verbalize that she don't have more itchy.
Pt presented with nausea and altered mental status, imaging confirmed a R pons ischemic stroke, later found to be due to basilar artery thrombosis
Large localized whelp with moderate to severe reaction. (L) arm central area of induration of 2.5 x 3 cm. Then subsequently erythema of 8X10 cm diameter.
Tinnitus.  Constant ringing in both ears started a few days after the 2nd vaccine.  My quality of life has significantly deteriorated and I regret ever getting this vaccine.
Approximately 11 days after vaccination pt developed non-pruritic red spots on her chest and back.  An Infectious Disease physician was consulted and the patient was determined to have an erythema multiforme reaction to the vaccine.  She returned to clinic the next day and the rash had essentially resolved.
Immun given 22FEB91 infant well @ that time;4MAR91 AM when mom noted child became "croupy sounding & fussy" no fever to MD dx w/ear infect mom reported MD vs she remembered this from informal consent form;
A non-serious spontaneous report of four bloody noses in 24 hours, headache, fever, sore throat and loss of appetite has been received from a consumer concerning her five-year-old son, subsequent to FLUMIST. Neither relevant medical history nor concomitant medications have been reported for this patient. The patient received FLUMIST on 04-Oct-2011. The patient experienced headache, fever, sore throat and loss of appetite. On 05-Oct-2011, the patient experienced four bloody noses in 24 hours. The outcome of events 4 bloody noses in 24 hours, headache, fever, sore throat and loss of appetite was not provided.
This spontaneous report as received from a licensed practical nurse refers to a 6 month old patient of unknown gender. No pertinent medical history or drug reactions/allergies were provided. The nurse reported that on 08-AUG-2014 the patient was vaccinated with a dose (unspecified in series) of ROTATEQ (lot number reported as K00145D, expiration date 18-NOV-2015), 2 ml, orally, that had been exposed to 1 deg. C for 4 hours. No adverse effects reported. This case is linked to cases MARRS # 1408USA015578 and MARRS # 1409USA002596 (same reporter link). Additional information has been requested.
PHOTOSENSITIVE RASH. Information has been received from a registered nurse (RN) concerning a female who was vaccinated with hepatitis B virus vaccine rHBsAg (yeast). The RN reported that 48 to 72 hours after being vaccinated the patient developed a sun rash. It was unknown if medical attention was sought. At the time of this report, the outcome was unknown. Additional information has been requested.
Following the shot I first developed vertigo then I developed a rash which was extremely itchy and painful.  The rash has persisted from April to present and is still raging.
This spontaneous report as received from a pharmacist refers to a 60 year old female patient. Medical history and drug allergies were reported as none. On 04-NOV-2014, the patient was vaccinated with ZOSTAVAX (dose: 0.65 ml, subcutaneous, anatomical location not reported, lot # K009200, expiration date 27-SEP-2015). Concomitant medication included: unspecified pain and hormonal medications. On an unspecified date, approximately in November 2014, date the patient developed redness and itchiness at the injection site. The patient sought medical attention via visit at pharmacy on 07-NOV-2014. The outcome of redness and itchiness at the injection site was not reported. The relatedness between the events and ZOSTAVAX was not provided. Additional information has been requested.
Tiredness, headache, muscle pain, nausea, feeling unwell , diahrea
Patient developed pain in the arm 5 days later, pain only occurs when lifting arm above head. There was no swelling at injection site. Pain is only at injection site.
Gradual loss of hearing and speech first noticed by mother roughly 3 weeks following administration of vaccines. She was diagnosed with severe sensorineural hearing loss less than 4 months later.
03/07/2000, within one week of receiving his 4th vaccine developed hives, one side of his face, lips was swollen and he had hives in axilla, back and abdomen. He sought medical care and was told to keep diary of foods, soaps and other contact items. He was prescribed Benadryl which did not help. Within a week he went back to Medical and was prescribed Zyrtec, which had no affect on his symptoms. His hive episodes would last 8-10 hours and then resolve to only reoccur in a few hours to a few days. He notes that his hands would itch and swell and within a 10-30 minutes to a day.  He was deployed in November 2002. He received your 5th vaccine in theater. Within a week he had a "Serious" breakout. He states he developed swelling of face, hands, feet, and hives over his trunk. He was given Benadryl in the field. He took the Benadryl and Zyrtec together. He had these episodes approximately ever 3 days. He notes that his hands continued to itch regardless of his intervention. In January 2003, he was seen in theater by an physician. He prescribed Allegra 180mg and Zantac 150 mg and he was instructed to take them at the same time. This would relieve his symptoms for 23 hours. After 23 hours the symptoms would come back with a vengeance, much worse than before.  He was instructed to once a month stop taking the medicine and see if his symptoms return. He continued to take the medications until February 2004. When he came off the medication, his hands started itching and his feet started swelling. He restarted the Allegra by itself. By April 2004, his symptoms had mostly resolved. He continues to have some swelling of his feet and itchy hands.  He received his 6th anthrax vaccine in August 2003. Again within a week he developed hives and urticaria as described in his previous vaccinations.  He states that before and after his deployment he told the physician who attended him that he had all the above symptoms; however he was told he was fine and would receive his vaccination and deploy as scheduled. He was told he could not see an allergist because he was leaving to soon.  Currently he is symptom free. The military wants to give him his annual anthrax booster when the injunction is lifted. He is concerned that his symptoms will once again return and escalate.
Patient had severe nausea, vomiting and headache. She was treated at the hospital.
Symptoms starts 9am with headache. For 3 times panadol q 4 hours 500mg.  At 8pm start fever (40.2 C), nauseas, dizzines, shaking chills and lost smell. Vomiting starts at 9:25 pm end 2:00 am. 01/08/2021 at 2:26 am visit Emergency Room, in clinic fainted and present high blood pressure 155/99. In hospital medication administred: Zofran, pepcid, .45 NSS and Phenergan IM at 01-08-2021.
Information has been received from a registered nurse concerning a 14 year old male with no known allergies who on 07/26/1996 was vaccinated with a dose of varicella virus vaccine live. On 01/31/2002 the pt presented to the doctor's office with varicella. The pt had chicken pox on the face, chest, shoulders, and had a low grade fever. The pt sought unspecified medical attention. Additional info has been requested.
Increase S.O.B. Following flu vaccine. ER -intubated and admitted.  11/12/2008 ER record received for 10/13/2008 with DX:  Respiratory failure/possible anaphylaxis, ? allergic reaction. Pt developed SOB which was progressing quickly despite nebs. En route to ER EMS tx with epi, solumedrol and albuterol nebs. Unable to speak on arrival with labored breathing and minimal air passage. PE (+) for unresponsive to commands, mottling, intercostal retractions, agonal respirations, and lethargic.  Intubated with return of responsiveness and increased alertness.
CHRONIC HYPOXEMIC RESPIRATORY FAILURE 8/12/2021 AFTERCARE FOR MUSCULOSKELETAL SYSTEM SURGERY  HYPOXIA 5/12/2021 AFTERCARE FOR MUSCULOSKELETAL SYSTEM SURGERY  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 8/12/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED  HYPOXIA 5/12/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED  CHRONIC HYPOXEMIC RESPIRATORY FAILURE 8/12/2021 ASTHMA COPD OVERLAP SYNDROME (ASTHMA W COPD)  HYPOXIA 5/12/2021 ASTHMA COPD OVERLAP SYNDROME (ASTHMA W COPD)